SSD Ostetricia e Ginecologia 2 - Fondazione IRCCS Policlinico San Matteo, Pavia
Pavia, 27100, Italy
Location status: Recruiting
NCT Number: NCT06872294
Infertility is the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse, while subfertility means a delay in achieving pregnancy. Several factors can contribute to these conditions, such as autoimmune diseases like systemic thyroid and celiac diseases, rheumatoid arthritis, systemic lupus erythematosus, and endometriosis. Some of them may overlap, sharing a common immunological milieu.
In this scenario, medically ART can help women carry on pregnancies if they are in stable disease remission and receive adequate treatment. However, the number of oocytes that can be ovulated under stimulation is highly variable, so the outcome of any IVF is linked to many factors, not only biological but also connected to the mean success rate of the fertility center.
For these reasons, the need to find methods for identifying the best gametes and embryos to guarantee a successful pregnancy is becoming pressing. AI can be essential to develop prediction models for pregnancy outcomes for patients undergoing ART treatments.
AI currently represents a modern way to obtain algorithms from a set of observable data that could help clinical decisions
Interested in participating?
Request Info18 year–43 year
Female
Observational
Pavia, 27100, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 2 years
Probability to achieve a pregnancy
Contact information is provided by the study sponsor or research team.
Fondazione IRCCS Policlinico San Matteo di Pavia
Other
Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome in Women Affected by Autoimmune Disorders: From Biological Markers to Artificial Intelligence
Acronym: AI-IVF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06948110
Autoimmune Diseases, Connective Tissue Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07699380
Autoimmune Diseases, Combination Therapy
Seattle, Washington, United States
View Trial DetailsNCT01351545
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL)
Birmingham, Alabama, United States
View Trial DetailsNCT04978948
Autoimmune Diseases, Immune System Diseases
Brest, France
View Trial Details